MARÍA DOLORES
CABALLERO BARRIGÓN
Forscherin in der Zeit 1998-2022
Washington University in St. Louis School of Medicine
San Luis, Estados UnidosPublikationen in Zusammenarbeit mit Forschern von Washington University in St. Louis School of Medicine (1)
2019
-
Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial
The Lancet, Vol. 393, Núm. 10168, pp. 229-240